Jeffrey M. Jonas
InvestorPartner at Cure Ventures · Board director at RYNE Biotechnology Inc.
Boston, Massachusetts, United States
About
Partner with over two decades in CNS drug discovery and development, contributing to medicines such as Lexapro, Vyvanse and Zulresso. Previously CEO of ABIO-X and CEO/Chief Innovation Officer at Sage Therapeutics.
Contact· self-published, not guessed
Board director at RYNE Biotechnology Inc.
Intro paths
→
In turn, Jeffrey can intro founders to RYNE Biotechnology Inc.'s investors below.
RYNE Biotechnology Inc.'s investors · 2
Experience
- Tortugas NeuroscieceChief Executive Officercurrent2026 — presentMassachusetts, United States
- Compass PathwaysDirectorcurrent2025 — presentUnited Kingdom
- Kenai TherapeuticsChairmancurrent2024 — presentUnited States
- Cure VenturesPartnercurrent2024 — present
- Noema PharmaChairman of the Boardcurrent2021 — present
- Karuna TherapeuticsDirector2015 — 2024
- Generation BioDirector2016 — 2024
- Sage TherapeuticsDirector2013 — 2023
- Sage TherapeuticsChief Executive Officer2013 — 2020Greater Boston Area
- ABio-XChief Executive Officer2022 — 2023
- Shire PharmaceuticalsPresident Shire Regenerative Medicine2012 — 2013
- Shire PharmaceuticalsSenior Vice President R&D - Specialty Pharma and Regenerative Medicine2011 — 2012
- Shire PharmaceuticalsSenior Vice President Research and Development2008 — 2011
- Isis PharmaceuticalsEVP2007 — 2008
- Forest LaboratoriesEVP/CMO2002 — 2007
- UpjohnChief Medical Officer/ VP Clinical Development1991 — 1996
Skills & more
IND2Clinical Development91Drug Development68Pharmaceutical Industry50Biotechnology44Clinical Trials38R&D37Biopharmaceuticals37Oncology21Neurology20Drug Discovery18Regulatory Affairs15
+12 more
Clinical ResearchRegulatory SubmissionsLifesciencesMedical DevicesFDACROInfectious DiseasesCross-functional Team LeadershipRegenerative MedicineCTMSNeuroscienceImmunologyFrom Jeffrey's professional profile.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Frequently asked questions
- Who is Jeffrey M. Jonas?
- Partner with over two decades in CNS drug discovery and development, contributing to medicines such as Lexapro, Vyvanse and Zulresso. Previously CEO of ABIO-X and CEO/Chief Innovation Officer at Sage Therapeutics.
- Where does Jeffrey M. Jonas work?
- Jeffrey M. Jonas is Partner at Cure Ventures and Board director at RYNE Biotechnology Inc..
- Where did Jeffrey M. Jonas go to school?
- Jeffrey M. Jonas studied at Harvard Medical School (MD); Amherst College (BA, Biology/English); Harvard Medical School.
Founder mafias
Harvard Medical School mafia28
Also came through, then founded or led a company.
Sangeeta N. BhatiaDoctor of Medicine (MD)Founded Port Therapeutics +3Lyle BerkowitzMedical informatics sub-fellowshipFounded Apollo Health +1Rushika FernandopulleM.D.Founded Iora HealthKevin BittermanPh.D.Founded Editas MedicineKush M ParmarMDFounded Homology Medicines
+ 22 more
Amherst College mafia16
Also came through, then founded or led a company.
Mike GamsonB.A.Founded EvozyneWilliam FordBachelor of Arts - BAFounded General AtlanticPhil EdmundsonB.S.Founded Corvus InsuranceItamar Har-EvenBAFounded IonpacificTim ShannonBAFounded Quarry TheraLindsay FitzgeraldFounded Vesey Ventures
+ 9 more
Cure Ventures mafia3
Also came through, then founded or led a company.
Generation Bio mafia3
Also came through, then founded or led a company.
RYNE Biotechnology Inc. mafia2
Also came through, then founded or led a company.
Same school
Also attended Harvard Medical School180
Niko BonatsosVerdict Capital founder and pre-consensus investor formerly at General CatalystAnthony PhilippakisInvestor at GV (Google Ventures)Ben RobbinsInvestor at GV (Google Ventures)David ReshefInvestor at GV (Google Ventures)Krishna YeshwantInvestor at GV (Google Ventures)Morgan CheathamPartner and Head of Healthcare and Life Sciences at Breyer Capital
.png)
+ 174 more
.png)
